drugset / Trial / NCT00956787
Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if AR-67 is effective in the treatment for patients with MDS.
Timeline
- Start
- 2009-06
- Primary completion
- 2014-07
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AR-67 | Small molecule | 7.5 mg/m2 | Intravenous |